Apyx Medical (NASDAQ:APYX) Posts Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Apyx Medical (NASDAQ:APYX) released its quarterly earnings data on Thursday. The company reported ($0.12) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.13) by $0.01, Zacks reports. Apyx Medical had a negative net margin of 58.59% and a negative return on equity of 137.98%. The company had revenue of $14.22 million during the quarter, compared to analyst estimates of $13.39 million. Apyx Medical updated its FY 2025 guidance to EPS.

Apyx Medical Price Performance

Apyx Medical stock opened at $1.04 on Friday. Apyx Medical has a 52-week low of $0.93 and a 52-week high of $1.99. The firm has a fifty day moving average of $1.42 and a 200-day moving average of $1.38. The firm has a market capitalization of $39.15 million, a P/E ratio of -1.25 and a beta of 1.18. The company has a quick ratio of 4.52, a current ratio of 5.46 and a debt-to-equity ratio of 3.03.

Apyx Medical Company Profile

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.